Загрузка...
Benefit from adrenocorticotrophin in myasthenia gravis
Twenty-one of 29 patients suffering from myasthenia gravis derived benefit from a short intensive course of adrenocorticotrophin (ACTH). The mean duration of benefit was approximately six months. The best results were obtained in patients with a short history of myasthenia. Transient deterioration d...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1974
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC494671/ https://ncbi.nlm.nih.gov/pubmed/4365243 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|